Literature DB >> 9835533

In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites.

O Ridoux1, M Drancourt.   

Abstract

In vitro comparisons demonstrated that the efficacy of albendazole, albendazole-sulfoxide, and albendazole-sulfone against pathogenic Encephalitozoon species was proportional to the degree of oxidation at a concentration of >10(-3) microgram/ml. Furthermore, at a concentration of <10(-2) microgram/ml, benzimidazoles were more effective against Encephalitozoon cuniculi and Encephalitozoon hellem than against Encephalitozoon intestinalis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835533      PMCID: PMC106041     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

Review 1.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

2.  The in vitro activity of albendazole against Encephalitozoon cuniculi.

Authors:  L M Weiss; E Michalakakis; C M Coyle; H B Tanowitz; M Wittner
Journal:  J Eukaryot Microbiol       Date:  1994 Sep-Oct       Impact factor: 3.346

3.  In vitro sensitivity of Encephalitozoon cuniculi and E. hellem to albendazole.

Authors:  O Ditrich; Z Kucerová; B Koudela
Journal:  J Eukaryot Microbiol       Date:  1994 Sep-Oct       Impact factor: 3.346

4.  Cryptosporidium and microsporidial beta-tubulin sequences: predictions of benzimidazole sensitivity and phylogeny.

Authors:  T Edlind; G Visvesvara; J Li; S Katiyar
Journal:  J Eukaryot Microbiol       Date:  1994 Sep-Oct       Impact factor: 3.346

5.  Rapid and sensitive method for the determination of albendazole and albendazole sulphoxide in biological fluids.

Authors:  P E Hoaksey; K Awadzi; S A Ward; P A Coventry; M L Orme; G Edwards
Journal:  J Chromatogr       Date:  1991-05-03

6.  In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi.

Authors:  B Beauvais; C Sarfati; S Challier; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 7.  Human microsporidial infections.

Authors:  R Weber; R T Bryan; D A Schwartz; R L Owen
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

8.  Use of albendazole for disseminated microsporidian infection in a patient with AIDS.

Authors:  M Lecuit; E Oksenhendler; C Sarfati
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

9.  Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole.

Authors:  R Weber; B Sauer; M A Spycher; P Deplazes; R Keller; R Ammann; J Briner; R Lüthy
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

10.  Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy.

Authors:  J M Molina; E Oksenhendler; B Beauvais; C Sarfati; A Jaccard; F Derouin; J Modaï
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

View more
  4 in total

1.  Analysis of the beta-tubulin genes from Enterocytozoon bieneusi isolates from a human and rhesus macaque.

Authors:  Donna E Akiyoshi; Louis M Weiss; Xiaochuan Feng; Bryony A P Williams; Patrick J Keeling; Quanshun Zhang; Saul Tzipori
Journal:  J Eukaryot Microbiol       Date:  2007 Jan-Feb       Impact factor: 3.346

Review 2.  Lack of in vitro antimicrosporidian activity of thalidomide.

Authors:  O Ridoux; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Analysis of the beta-tubulin gene and morphological changes of the microsporidium Anncaliia algerae both suggest albendazole sensitivity.

Authors:  Marianita Santiana; Cyrilla Pau; Peter M Takvorian; Ann Cali
Journal:  J Eukaryot Microbiol       Date:  2014-09-15       Impact factor: 3.346

4.  A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia.

Authors:  Laura R Serbus; Frederic Landmann; Walter M Bray; Pamela M White; Jordan Ruybal; R Scott Lokey; Alain Debec; William Sullivan
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.